Efficacy and Safety of a Probiotic Composition as Adjunct in MAFL Management
Efficacy and Safety of a Probiotic Composition as Adjunct Treatment in the Comprehensive Management of Metabolism-Associated Hepatic Steatosis in Adults
Sponsor: AB Biotics, SA
This NA trial investigates Non Alcoholic Fatty Liver and is currently completed. AB Biotics, SA leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Mar 2022 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2022 — Mar 2022 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 1 earlier version
-
May 2021 — Jan 2022 [monthly]
Recruiting NA
First recorded
Mar 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AB Biotics, SA
For direct contact, visit the study record on ClinicalTrials.gov .